EUVIMEDEUVIMED entdecken
Crossref

Revisiting mortality in acromegaly using machine learning

Cem Sulu, Gonenc Onay, Guldaran Bakhdiyarli, Serdar Sahin, Emre Durcan, Zehra Kara, Ahmet Numan Demir, Ozgur Martin, Hande Mefkure Ozkaya, Necmettin Tanriover, Nil Comunoglu, Osman Kizilkilic und 2 weitere

Endocrine · 2025

DOI: 10.1007/s12020-025-04422-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrine, 2025. Verfasst von Cem Sulu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology-Metabolism and Diabetes, Department of Internal Medicine, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, I…. Hauptthemen laut MEDLINE: Acromegaly, Machine Learning. Die Arbeit nennt 63 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To evaluate predictors of mortality in acromegaly using machine learning (ML) models. METHODS: We analyzed 607 patients with acromegaly. A grid search was applied to compare five types of prediction models in 1,200 configurations. Each model predicted mortality based on 40 disease characteristics, assessed using the Matthews’ correlation coefficient (MCC) and the area under the curve (AUC) metrics. To ensure robust and reliable predictions, we constructed a virtual ensemble model by generating 100 Explainable Boosting Machine (EBM) variants and evaluating their performance across 50 random train–test splits. RESULTS: The single EBM model fitted to all data achieved an MCC of 0.88 and an AUC of 0.99. Feature importance analysis identified hypertension, first-line transsphenoidal surgery (TSS), disease duration, baseline insulin-like growth factor 1 levels, hypopituitarism, and repeat TSS as key predictors of mortality. A virtual ensemble prediction model showed good generalization performance, with an MCC of 0.64 ± 0.08 and an AUC of 0.96 ± 0.015 across 50 random data splits. 58% of the cohort were female, and 66.9% had macroadenomas. The first-line treatment was TSS in 83.2% of cases. Additional treatments were repeat TSS (16.6%), somatostatin analogs (57%), cabergoline (35.6%), pegvisomant (10.9%), and radiotherapy (16.6%), achieving a 77.8% overall success rate. Hypertension (37.2%) and diabetes (36.4%) were the most common comorbidities. The mortality rate was 8.4%, mainly from cardiovascular disease (41.2%) and cancer (21.6%). CONCLUSION: ML demonstrated strong performance in classifying survival status and identifying mortality predictors in acromegaly. The ensemble model provides a reliable and interpretable tool, balancing accuracy with the robustness required for clinical decision-making.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AcromegalyMachine LearningHumansFemalePredictive Learning ModelsMaleMiddle AgedAdultBoosting Machine Learning AlgorithmsAgedPrediction Algorithms

Stichwörter der Autor:innen

AcromegalyHypertensionMachine learningMortalityTranssphenoidal surgery

Autor:innen und Institutionen

  • Division of Endocrinology-Metabolism and Diabetes, Department of Internal Medicine, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Faculty of Art and Science, Galatasaray University, Istanbul, Turkey.
  • Department of Internal Medicine, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Faculty of Art and Science, Mimar Sinan Fine Arts University, Istanbul, Turkey.
  • Pituitary Center, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Department of Neurosurgery, Cerrahpasa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.

ORCID-Profile: Pinar Kadioglu

Zitieren

APA

Sulu, C., Onay, G., Bakhdiyarli, G., Sahin, S., Durcan, E., Kara, Z., Demir, A. N., Martin, O., Ozkaya, H. M., Tanriover, N., Comunoglu, N., Kizilkilic, O., Gazioglu, N., & Kadioglu, P. (2025). Revisiting mortality in acromegaly using machine learning. Endocrine. https://doi.org/10.1007/s12020-025-04422-5

Vancouver

Sulu C, Onay G, Bakhdiyarli G, Sahin S, Durcan E, Kara Z, et al. Revisiting mortality in acromegaly using machine learning. Endocrine. 2025. doi:10.1007/s12020-025-04422-5

BibTeX
@article{Sulu2025,
  author = {Sulu, Cem and Onay, Gonenc and Bakhdiyarli, Guldaran and Sahin, Serdar and Durcan, Emre and Kara, Zehra and Demir, Ahmet Numan and Martin, Ozgur and Ozkaya, Hande Mefkure and Tanriover, Necmettin and Comunoglu, Nil and Kizilkilic, Osman and Gazioglu, Nurperi and Kadioglu, Pinar},
  title = {Revisiting mortality in acromegaly using machine learning},
  journal = {Endocrine},
  year = {2025},
  doi = {10.1007/s12020-025-04422-5}
}
Kostenlos starten →